| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00007890-199202010-00013 |
| P953 | full work available at URL | http://journals.lww.com/00007890-199202010-00013 |
| P698 | PubMed publication ID | 1738926 |
| P2093 | author name string | MacDonald AS | |
| A. S. MacDonald | |||
| P. Belitsky | |||
| A. C. Gulanikar | |||
| U. Sungurtekin | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 323-328 | |
| P577 | publication date | 1992-02-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants | |
| P478 | volume | 53 |
| Q33871850 | A Systematic Review and Meta-analysis of Prophylactic versus Pre-emptive Strategies for Preventing Cytomegalovirus Infection in Renal Transplant Recipients |
| Q40999048 | A cost-effectiveness analysis of OKT3 induction therapy in cadaveric kidney transplantation |
| Q73483191 | Absence of deleterious effect on long-term kidney graft survival of rejection episodes with complete functional recovery |
| Q57623303 | Acute rejection and the therapeutic choice of drug |
| Q73279235 | Acute rejection episodes predict long-term renal transplantation survival |
| Q77176025 | Acute rejection is a major risk factor for chronic rejection |
| Q34006687 | Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation |
| Q36432665 | Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients |
| Q43120235 | Biological mechanism analysis of acute renal allograft rejection: integrated of mRNA and microRNA expression profiles |
| Q50999369 | Causes of long-term graft failure in renal transplantation. |
| Q30922911 | Characterization of Renal Allograft Rejection by Urinary Proteomic Analysis |
| Q71754587 | Chronic renal allograft rejection can be predicted by area under the serum creatinine versus time curve (AUCCr) |
| Q79781694 | Clinical trial of Tripterygium Wilfordii Hook F. in human kidney transplantation in China |
| Q36062030 | Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens |
| Q71630658 | Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation |
| Q40380386 | Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation |
| Q52069311 | Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practice. |
| Q43552820 | Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression |
| Q55303250 | Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes. |
| Q46819583 | Does mycophenolate mofetil decrease the recurrent acute rejection in renal transplant recipients |
| Q60542042 | Effects of Brain Death and Hemodynamic Status on Function and Immunologic Activation of the Potential Donor Liver in the Rat |
| Q44287734 | Factors affecting long-term renal allograft survival in cyclosporine-treated kidney transplants |
| Q44220297 | Factors contributing to long graft survival in non-heart-beating cadaveric renal transplantation in Japan: a single-center study at Kitasato University |
| Q74480628 | Impact of acute rejection on long-term graft survival in HLA-identical living-related kidney transplants |
| Q43782400 | Impact of mycophenolate mofetil on recurrent rejection in kidney transplant patients |
| Q41214653 | In vivo pharmacological effects of ciclosporin and some analogues |
| Q37563386 | Interpreting the proteome and peptidome in transplantation. |
| Q50636042 | Is acute rejection deleterious to long-term liver allograft function? |
| Q34372170 | Kidney transplantation from non heart-beating donors |
| Q42169081 | Kidney transplantation from non-heart-beating donors: analysis of organ procurement and outcome |
| Q44064648 | Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation |
| Q72024442 | Long-term renal function in cyclosporine-treated renal allograft recipients |
| Q26740172 | Mechanisms and risk assessment of steroid resistance in acute kidney transplant rejection |
| Q44101510 | Mycophenolate mofetil reduces late renal allograft loss: a 4-year study |
| Q41113157 | Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation |
| Q40864393 | Organ transplantation in the twenty-first century |
| Q30239091 | Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. |
| Q74617362 | Predisposing factors in the development of chronic allograft dysfunction |
| Q37869065 | Profiling the proteome in renal transplantation |
| Q47887130 | Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group |
| Q74402827 | Rejection profile of recent pediatric renal transplant recipients compared with historical controls: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) |
| Q40937496 | Renal allograft and patient outcome after transplantation: pancreas-kidney versus kidney-alone transplants in type 1 diabetic patients versus kidney-alone transplants in nondiabetic patients |
| Q36895544 | Renal transplantation in high-risk patients |
| Q77369675 | Renal transplantation with Simulect (basiliximab) plus Sandimmune Neoral-based immunosuppression: a report of 41 cases in Taiwan |
| Q74701733 | Risk factors for chronic rejection--a clinical perspective |
| Q73304091 | Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients |
| Q42169372 | Selective use of mycophenolate mofetil in renal transplant patients in Indian scenario |
| Q40582646 | Serum C-reactive protein in pediatric kidney and liver transplant patients |
| Q33903986 | Shotgun proteomics identifies proteins specific for acute renal transplant rejection. |
| Q77758328 | Significance of chronic transplant nephropathy on early protocol biopsies for graft outcome in pediatric renal transplantation |
| Q74617283 | Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors |
| Q44352685 | Single center analysis of mycophenolate mofetil and Neoral/prednisone therapy for prophylaxis of rejection in African-American and Caucasian transplant recipients |
| Q39393606 | Study of CC chemokine receptor 5 in renal allograft rejection |
| Q41449031 | The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes |
| Q34421534 | The impact of late acute rejection after cadaveric kidney transplantation |
| Q41696119 | The role of HLA in renal transplantation |
| Q33957200 | The use of mycophenolate mofetil in transplant recipients |
| Q79819511 | Therapeutic monitoring of cyclosporine in kidney transplantation: the Halifax experience |
| Q73027347 | Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation |
| Q38464536 | Use of cyclosporine pharmacokinetic profiles in an antibody induction protocol reduces early acute rejection rates in recipients of primary cadaveric renal allografts |
| Q42169514 | Use of simulect can reduce the incidence of acute rejection and demonstrates with superior 3-year patient and graft survival rates in renal transplantation |
| Q44419281 | WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation1 |
Search more.